THYMMUNE THERAPEUTICS INC
Restoring Immune Function through Thymic Cell Engineering
Cambridge, United States · Founded 2022
- Headquarters
- Cambridge, Massachusetts
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- thymmune.com
About
Thymmune Therapeutics is a Cambridge-based biotech developing an iPSC-derived thymic cell engineering platform to restore immune function in patients with immunodeficiencies, autoimmune disorders, and transplant complications. Its lead program THY-100 targets thymic deficiencies, and the company received up to $37M from ARPA-H for thymus rejuvenation research.
Summary
THYMMUNE THERAPEUTICS INC is a Biotech company based in Cambridge, United States, founded in 2022.
Tech & App Stack
11 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/thymmune-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/thymmune-therapeutics-inc" alt="THYMMUNE THERAPEUTICS INC on Indexed.vc" width="260" height="76" /></a>